Stryker Acquires Artelon, Enhancing its Portfolio of Soft Tissue Fixation Solutions
Shots:
- Stryker has agreed to acquire all the outstanding shares of Artelon. The transaction is contingent upon customary closing conditions; both the companies will operate as separate entities until the deal closure
- The acquisition will add Artelon’s technologies to Stryker’s portfolio, enhancing its products offered to sports medicine as well as foot & ankle consumers. Artelon’s other synthetic technology, developed for improving biological along with mechanical ligament & tendon reconstruction, will further strengthen Stryker’s offerings
- Additionally, through the acquisition, Stryker will be able to compete in the sports medicine as well as foot & ankle markets with the biomaterial technology that promotes the healing of the patient's soft tissues
Ref: Businesswire | Image: Stryker
Related News: Stryker Signs a Definitive Agreement to Acquire Vocera Communications for ~$3.09B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
